|   | 
 Meeting No. 
 | 
  | 
 Title 
 | 
  | 
 Date 
 | 
  | 
 Presenter 
 | 
  | 
  | 
|   | 
 22 
 | 
  | 
 | 
  | 
 23/10/89 
 | 
  | 
  | 
  | 
  | 
|   | 
 21 
 | 
  | 
   
 | 
  | 
 18/9/89 
 | 
  | 
 Dr. Babaee, Mansour  
 | 
  | 
  | 
|   | 
 20 
 | 
  | 
   
 | 
  | 
 6/8/89 
 | 
  | 
  | 
  | 
  | 
|   | 
 19 
 | 
  | 
 Algorithm for the Management of Osteoporosis 
 | 
  | 
  | 
  | 
 Dr. Babaee, Mansour 
 | 
  | 
  | 
|   | 
 18 
 | 
  | 
   
 | 
  | 
15/7/89 | 
  | 
 Dr. Ebrahimi 
 | 
  | 
  | 
|   | 
 17 
 | 
  | 
   
 | 
  | 
 8/7/89  
 | 
  | 
 Dr. Babaee, Mansour 
 | 
  | 
  | 
|   | 
 16 
 | 
  | 
   
 | 
  | 
 25/6/89  
 | 
  | 
 Dr. Abrishami, Masoud 
 | 
  | 
  | 
|   | 
 15 
 | 
  | 
   
 | 
  | 
 18/6/89 
 | 
  | 
  | 
  | 
  | 
|   | 
 14 
 | 
  | 
   
 | 
  | 
 11/6/89 
 | 
  | 
 Dr. Ghazi Saeedi, Mehran 
 | 
  | 
  | 
|   | 
 13 
 | 
  | 
   
  
 | 
  | 
 4/6/89 
 | 
  | 
 Dr. Ghazi Saeedi, Mehran 
 | 
  | 
  | 
|   | 
 12 
 | 
  | 
   
 | 
  | 
 28/5/89 
 | 
  | 
 Dr. Abrishami, Masoud 
 | 
  | 
  | 
|   | 
 11 
 | 
  | 
   
 | 
  | 
 21/5/89 
 | 
  | 
 Dr. Ghazi Saeedi, Mehran 
 | 
  | 
  | 
|   | 
 10 
 | 
  | 
   
 | 
  | 
 14/5/89 
 | 
  | 
 Dr. Gholami, Farhad 
 | 
  | 
  | 
|   | 
 9 
 | 
  | 
 | 
  | 
 31/4/89 
 | 
  | 
 Dr. Ghazi Saeedi, Mehran 
 | 
  | 
  | 
|   | 
 8 
 | 
  | 
   
 | 
  | 
 17/4/89 
 | 
  | 
 Dr. Hassanzade 
 | 
  | 
  | 
|   | 
 7 
 | 
  | 
   
 | 
  | 
 3/4/89 
 | 
  | 
 Dr. Sedygh 
 | 
  | 
  | 
|   | 
 6 
 | 
  | 
   
 | 
  | 
 20/3/89 
 | 
  | 
 Dr. Ghazi Saeedi, Mehran 
 | 
  | 
  | 
|   | 
 5 
 | 
  | 
 The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled  
  
 | 
  | 
  | 
  | 
  | 
  | 
  | 
|   | 
 4 
 | 
  | 
   
 | 
  | 
  | 
  | 
 Dr. Hashemzade, Kamelia 
 | 
  | 
  | 
|   | 
 3 
 | 
  | 
   
 | 
  | 
  | 
  | 
  | 
  | 
  | 
|   | 
 2 
 | 
  | 
 Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study 
  
 | 
  | 
  | 
  | 
  | 
  | 
  | 
|   | 
 1 
 | 
  | 
   
 | 
  | 
  | 
  | 
  | 
  | 
  | 
|   | 
  | 
  | 
  | 
  | 
  | 
  | 
  | 
  | 
  |